Johns Hopkins Awards Cancer Research Scholarships to 2 PhDs

Two PhD students at Johns Hopkins Bloomberg School of Public Health are getting crucial support to continue their groundbreaking cancer research.

Jon Vose from the Kavran Lab received the David and Elinor Bodian Scholarship to study why some cancers resist chemotherapy treatment. His research focuses on a novel mechanism that could explain why certain tumors stop responding to drugs that initially worked.

The scholarship honors Dr. David Bodian, whose research helped develop the polio vaccine, and his wife Elinor. It supports doctoral students at critical points in their dissertation research.

Angel Pajimola from the Jenkins-Lord Lab earned the Carol Eliasberg Martin Scholarship for work that could explain breast cancer disparities. She's investigating how a tumor suppressor protein called LRIG1 interacts with environmental factors, potentially revealing why breast cancer affects different populations differently.

The Martin Scholarship specifically supports research into cancers affecting women, with a focus on breast and ovarian cancer. It honors Carol Eliasberg Martin, who died in 1997 after fighting cancer.

Both students work in the Biochemistry and Molecular Biology department, where PhD candidates study biological systems to tackle major health challenges. Their lab work combines basic science with real world public health applications.

The Ripple Effect

These scholarships do more than fund individual projects. By supporting research into chemotherapy resistance, Vose's work could eventually help doctors choose better treatment strategies for patients whose cancers have stopped responding.

Pajimola's focus on cancer disparities addresses a critical gap in medical research. Understanding why certain populations face higher cancer risks or worse outcomes could lead to more targeted prevention strategies and treatments.

The scholarships rotate annually between different Bloomberg School departments and the doctoral program, ensuring consistent support for emerging researchers across multiple health disciplines.

Both awards recognize not just academic excellence but the potential for research to create meaningful change in how we prevent and treat disease.

Two young scientists now have the resources to push forward work that could save lives for years to come.